Elevated Fmr1 MRNA Levels and Reduced Protein Expression in a Mouse Model with an Unmethylated Fragile X Full Mutation

Overview

Journal Exp Cell Res

Specialty Cell Biology

Date 2006 Dec 8

PMID 17150213

Citations 78

Authors

J R Brouwer

E J Mientjes

C E Bakker

I M Nieuwenhuizen

L A Severijnen

H C Van der Linde

D L Nelson

B A Oostra

R Willemsen

Affiliations

Soon will be listed here.

Abstract

The human FMR1 gene contains a CGG repeat in its 5' untranslated region. The repeat length in the normal population is polymorphic (5-55 CGG repeats). Lengths beyond 200 CGGs (full mutation) result in the absence of the FMR1 gene product, FMRP, through abnormal methylation and gene silencing. This causes Fragile X syndrome, the most common inherited form of mental retardation. Elderly carriers of the premutation, defined as a repeat length between 55 and 200 CGGs, can develop a progressive neurodegenerative syndrome: Fragile X-associated tremor/ataxia syndrome (FXTAS). In FXTAS, FMR1 mRNA levels are elevated and it has been hypothesised that FXTAS is caused by a pathogenic RNA gain-of-function mechanism. We have developed a knock in mouse model carrying an expanded CGG repeat (98 repeats), which shows repeat instability and displays biochemical, phenotypic and neuropathological characteristics of FXTAS. Here, we report further repeat instability, up to 230 CGGs. An expansion bias was observed, with the largest expansion being 43 CGG units and the largest contraction 80 CGG repeats. In humans, this length would be considered a full mutation and would be expected to result in gene silencing. Mice carrying long repeats ( approximately 230 CGGs) display elevated mRNA levels and decreased FMRP levels, but absence of abnormal methylation, suggesting that modelling the Fragile X full mutation in mice requires additional repeats or other genetic manipulation.

Citing Articles

Beyond the Synapse: and FMRP Molecular Mechanisms in the Nucleus.

Hansen N, Dischler A, Dias C Int J Mol Sci. 2025; 26(1.

PMID: 39796070 PMC: 11720320. DOI: 10.3390/ijms26010214.

From wings to whiskers to stem cells: why every model matters in fragile X syndrome research.

Sandoval S, Mendez-Albelo N, Xu Z, Zhao X J Neurodev Disord. 2024; 16(1):30.

PMID: 38872088 PMC: 11177515. DOI: 10.1186/s11689-024-09545-w.

Directly reprogrammed fragile X syndrome dorsal forebrain precursor cells generate cortical neurons exhibiting impaired neuronal maturation.

Edwards N, Combrinck C, McCaughey-Chapman A, Connor B Front Cell Neurosci. 2023; 17:1254412.

PMID: 37810261 PMC: 10552551. DOI: 10.3389/fncel.2023.1254412.

Mouse models of fragile X-related disorders.

Willemsen R, Kooy R Dis Model Mech. 2023; 16(2).

PMID: 36692473 PMC: 9903145. DOI: 10.1242/dmm.049485.

341 Repeats Is Not Enough for Methylation in a New Fragile X Mouse Model.

Colvin S, Lea N, Zhang Q, Wienisch M, Kaiser T, Aida T eNeuro. 2022; 9(5).

PMID: 35977823 PMC: 9469916. DOI: 10.1523/ENEURO.0142-22.2022.

References

Tassone F, Hagerman R, Taylor A, Gane L, Godfrey T, Hagerman P . Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet. 2000; 66(1):6-15. PMC: 1288349. DOI: 10.1086/302720. View

Grigsby J, Brega A, Jacquemont S, Loesch D, Leehey M, Goodrich G . Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J Neurol Sci. 2006; 248(1-2):227-33. DOI: 10.1016/j.jns.2006.05.016. View

Oswald J, Engemann S, Lane N, Mayer W, Olek A, Fundele R . Active demethylation of the paternal genome in the mouse zygote. Curr Biol. 2000; 10(8):475-8. DOI: 10.1016/s0960-9822(00)00448-6. View

Sherman S . Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?. Am J Hum Genet. 2000; 67(1):11-3. PMC: 1287068. DOI: 10.1086/302985. View

Bakker C, de Diego Otero Y, Bontekoe C, Raghoe P, Luteijn T, Hoogeveen A . Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res. 2000; 258(1):162-70. DOI: 10.1006/excr.2000.4932. View

Hagerman R, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J . Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001; 57(1):127-30. DOI: 10.1212/wnl.57.1.127. View

Kenneson A, Zhang F, Hagedorn C, Warren S . Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet. 2001; 10(14):1449-54. DOI: 10.1093/hmg/10.14.1449. View

Bontekoe C, Bakker C, Nieuwenhuizen I, van der Linde H, Lans H, de Lange D . Instability of a (CGG)98 repeat in the Fmr1 promoter. Hum Mol Genet. 2001; 10(16):1693-9. DOI: 10.1093/hmg/10.16.1693. View

Pietrobono R, Pomponi M, Tabolacci E, Oostra B, Chiurazzi P, Neri G . Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res. 2002; 30(14):3278-85. PMC: 135754. DOI: 10.1093/nar/gkf434. View

10.

Peier A, Nelson D . Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. Genomics. 2002; 80(4):423-32. DOI: 10.1006/geno.2002.6849. View

11.

Primerano B, Tassone F, Hagerman R, Hagerman P, Amaldi F, Bagni C . Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA. 2003; 8(12):1482-8. PMC: 1370354. View

12.

Nolin S, Brown W, Glicksman A, Houck Jr G, Gargano A, Sullivan A . Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet. 2003; 72(2):454-64. PMC: 379237. DOI: 10.1086/367713. View

13.

Willemsen R, Hoogeveen-Westerveld M, Reis S, Holstege J, Severijnen L, Nieuwenhuizen I . The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet. 2003; 12(9):949-59. DOI: 10.1093/hmg/ddg114. View

14.

Fleming K, Riser D, Kumari D, Usdin K . Instability of the fragile X syndrome repeat in mice: the effect of age, diet and mutations in genes that affect DNA replication, recombination and repair proficiency. Cytogenet Genome Res. 2003; 100(1-4):140-6. DOI: 10.1159/000072848. View

15.

Beilina A, Tassone F, Schwartz P, Sahota P, Hagerman P . Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element. Hum Mol Genet. 2004; 13(5):543-9. DOI: 10.1093/hmg/ddh053. View

16.

Allen E, He W, Yadav-Shah M, Sherman S . A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet. 2004; 114(5):439-47. DOI: 10.1007/s00439-004-1086-x. View

17.

Tassone F, Hagerman R, Garcia-Arocena D, Khandjian E, Greco C, Hagerman P . Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet. 2004; 41(4):e43. PMC: 1735735. DOI: 10.1136/jmg.2003.012518. View

18.

Stoyanova V, Oostra B . The CGG repeat and the FMR1 gene. Methods Mol Biol. 2004; 277:173-84. DOI: 10.1385/1-59259-804-8:173. View

19.

Monk M, Boubelik M, Lehnert S . Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development. 1987; 99(3):371-82. DOI: 10.1242/dev.99.3.371. View

20.

Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A . Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 1991; 252(5009):1097-102. DOI: 10.1126/science.252.5009.1097. View